DKK1 and prostate cancer: It is suggested that tumor establishment necessitates the initial upregulation of DKK1, while a reduction in DKK1 during bone metastasis can lead to an increase in WNT expression, resulting in osteoblastic metastases that are traditionally associated with prostate cancer [123,124].